Research Article
Biological Impact of Pd (II) Complexes: Synthesis, Spectral Characterization, In Vitro Anticancer, CT-DNA Binding, and Antioxidant Activities
Table 1
LC50, TGI, and GI50 values (µg/mL) against MCF7 and MDA-MB-231 cell lines of complexes, an anticancer analysis.
| | Entry | Complexes | Drug concentrations (µM) calculated from graph | | MCF7 | MDA-MB-231 | | LC50 | TGI | GI50 | LC50 | TGI | GI50 |
| | 1 | Pd2MBA | >80 | 79.4 | 27.5 | >80 | >80 | 61.5 | | 2 | Pd3MBA | >80 | 75.6 | 30.1 | >80 | >80 | 44.6 | | 3 | Pd4MBA | >80 | >80 | 78.4 | >80 | >80 | >80 | | 4 | ADR | 79.2 | 40.5 | <10 | 39.85 | <10 | <10 | | 5 | Cisplatin | >30 | >30 | <10 | >30 | >30 | <10 |
|
|
